|
|
|
Volumn 153, Issue 42, 2008, Pages 23-
|
|
Epoetin biosimilar: Cost-saving potential is still not exhausted;Epoetin-biosimilar: Sparpotenzial noch nicht ausgereizt
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HEXAL;
RECOMBINANT ERYTHROPOIETIN;
UNCLASSIFIED DRUG;
ANEMIA;
CANCER PATIENT;
CHRONIC KIDNEY FAILURE;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
HEMODIALYSIS;
HUMAN;
NOTE;
PERITONEAL DIALYSIS;
|
|
EID: 55249124264
PISSN: 00317136
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
